These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16331099)

  • 1. Development of the metabolic syndrome along the female biological life-path.
    Esler M; Wiesner G
    J Hypertens; 2006 Jan; 24(1):43-5. PubMed ID: 16331099
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin resistance and sympathetic overactivity in women.
    Kaaja RJ; Pöyhönen-Alho MK
    J Hypertens; 2006 Jan; 24(1):131-41. PubMed ID: 16331111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of the sympathetic nervous system during therapy for hypertension and related pathologies. Imidazoline-I1-receptor agonists. 17th Scientific Meeting of the International Society of Hypertension. Amsterdam, June 7, 1998].
    Dtsch Med Wochenschr; 1998 Aug; 123(33 Suppl):1-4. PubMed ID: 9739350
    [No Abstract]   [Full Text] [Related]  

  • 4. The sympathetic nervous system alterations in human hypertension.
    Grassi G; Mark A; Esler M
    Circ Res; 2015 Mar; 116(6):976-90. PubMed ID: 25767284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.
    Reaven GM; Lithell H; Landsberg L
    N Engl J Med; 1996 Feb; 334(6):374-81. PubMed ID: 8538710
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome.
    Tsioufis C; Dimitriadis K; Kasiakogias A; Kalos T; Liatakis I; Koutra E; Nikolopoulou L; Kordalis A; Ella RO; Lau EO; Grassi G; Papademetriou V; Tousoulis D
    J Hypertens; 2017 May; 35(5):1100-1108. PubMed ID: 28106665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [[Central agents in arterial hypertension: back to the future].
    Robles NR
    Nefrologia; 2000; 20(4):302-10. PubMed ID: 11039256
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolic syndrome: insulin resistance.
    Mikhail N
    Curr Hypertens Rep; 2009 Apr; 11(2):156-8. PubMed ID: 19278606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk.
    Julius S; Gudbrandsson T
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S40-8. PubMed ID: 1283769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic imbalance and metabolic syndrome: unravelling interactions, mechanisms and outcomes.
    Grassi G; Seravalle G
    J Hypertens; 2006 Jan; 24(1):47-9. PubMed ID: 16331100
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin resistance and the metabolic syndrome.
    Lann D; Gallagher E; Leroith D
    Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective imidazoline receptor agonists for metabolic syndrome.
    Krentz AJ; Evans AJ
    Lancet; 1998 Jan; 351(9097):152-3. PubMed ID: 9449863
    [No Abstract]   [Full Text] [Related]  

  • 14. Sympathetic and baroreflex function in hypertension: implications for current and new drugs.
    Grassi G
    Curr Pharm Des; 2004; 10(29):3579-89. PubMed ID: 15579055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic neural activity in hypertension and related diseases.
    Grassi G
    Am J Hypertens; 2010 Oct; 23(10):1052-60. PubMed ID: 20651696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the relationship between sympathetic activity and inflammation.
    Hausberg M; Hillebrand U; Kisters K
    J Hypertens; 2008 Dec; 26(12):2276-8. PubMed ID: 19008705
    [No Abstract]   [Full Text] [Related]  

  • 17. [Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence].
    Soucek M; Nevrlka J; Rihácek I; Frána P; Plachý M
    Vnitr Lek; 2007 May; 53(5):554-9. PubMed ID: 17642445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive drugs and the sympathetic nervous system.
    Del Colle S; Morello F; Rabbia F; Milan A; Naso D; Puglisi E; Mulatero P; Veglio F
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):487-96. PubMed ID: 18030057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and sympathetic effects of reversing insulin resistance in hypertension.
    Grassi G
    J Hypertens; 2004 Sep; 22(9):1671-2. PubMed ID: 15311091
    [No Abstract]   [Full Text] [Related]  

  • 20. Women, menopause, and the metabolic syndrome.
    Drown DJ
    Prog Cardiovasc Nurs; 2006; 21(1):51-2. PubMed ID: 16522971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.